Richard C. Pettus is a trial lawyer with more than 20 years of experience in patent matters. He has represented clients in over 75 patent litigations, including more than a dozen trials to verdict that span a wide range of technologies, including pharmaceuticals, computer software and hardware, medical devices, semiconductors, polymers, “green” technology, energy and industrial equipment, fiber optics, chemical processes and consumer products.
In the biopharmaceutical and ANDA Hatch-Waxman area, Rich has served as lead counsel for companies such as Teva Pharmaceuticals, Baxter Healthcare, BioMarin Pharmaceutical, Boehringer-Ingelheim Vetmedica, B. Braun Medical Inc., Dr. Reddy’s Laboratories, Emcure Pharmaceuticals, GlaxoSmithKline, Glenmark Pharmaceuticals, and Sanofi, in matters involving small and large drug molecules, their polymorphic, enantiomeric and pegylated forms, combinations, uses and formulations as well as devices for injectable, oral and inhaled drug delivery, DNA constructs, vaccines, manufacturing processes and diagnostic kits. He also conducts Hatch-Waxman pre-litigation assessments to help prepare pharmaceutical clients for patent challenges.
Rich counsels Fortune 250 and emerging technology companies and investors on intellectual property management and other proprietary technology related issues, including strategies for patent due diligence, pre-litigation investigations, licensing and patent prosecution. He is also involved in the training of in-house legal and business/management teams on patent, Hatch-Waxman and life cycle management related issues.